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Retinoic acid (RA) affects limb-skeletal pattern in vivo through specific
interactions with DNA-binding, nuclear retinoid receptors (RARs and RXRs). RA
activity is mediated via cytoplasmic retinoic-acid binding proteins (CRABPs). In serum-
free cultures, wing mesenchyme cells show age- and region-dependent RA
responsiveness not entirely accounted for by RAR and RXR expression patterns. The
proximodistal expression pattern ofCRABP may affect RA metabolism patterns and thus
the retinoids encountered by the nuclear receptors within the wing mesenchyme during
outgrowth. Mesenchymal cells, isolated from the proximal and distal regions of the wing,
at different developmental stages, were incubated with physiologic or pharmacologic
concentrations of all-/rans-RA mixed with radiolabeled RA (^H-all-Zram-RA) in order to
determine RA metabolism and identify RA metabolites along the proximodistal axis.
Culture extracts, subjected to reverse phase HPLC and scintillation covmting, revealed
age- and region-dependent RA metabolism in terms of rate and metabolites produced.
Western blots ofnon-denaturing gel electrophoresed proteins isolated from the proximal
and distal regions showed corresponding differences in CRABP isoform expression.
Greater CRABP II expression was noted in the distal mesenchyme, where RA
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metabolism is enhanced. CRABPI expression is prevalent in cells isolated from the
proximal region. These results suggest that CRABP isoform distribution may account for
patterns ofRA responsiveness through their role in RA metabolism.
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I. Introduction
Vitamin A (retinol) and its derivatives, the retinoids, comprise a class of fat-
soluble compounds that are essential for normal growth, vision, reproduction, and
differentiation. Retinoid is a generic term applied to all the naturally occurring
compounds with vitamin A activity, and tosynthetic analogs having some or all of
retinol’s biological activities. Carotenoids (e.g., B-carotene) are naturally occurring
precursors of the retinoids, but are not considered retinoidsper se.
Retinoids induce biochemical, morphological and functional changes in epithelial
cells and have thus been explored as treatments for a variety of skin diseases (Fritsch,
1981, 1992; Parkinson et al, 1992). However, using oral retinoids in such therapy is risky
because of their frequent broad spectrum toxicities, including teratogenic effects on
developing embryos (Kochhar, 1973; Lammer et al. 1985; David, Hodak, and Lowe,
1988; Willhite and Dawson, 1990; Armstrong et al. 1994). Exposure to systemic
(absorbed) retinoids has been associated with limb deformities, craniofacial defects and
other congenital malformations (Willhite, et. al., 1990; Creech-Krafl, et. al., 1991;
Agnish, et. al., 1990; Lofberg, et. al., 1990; Lammer, et. al., 1985; Rizzo et al. 1991;
Morriss-Kay, 1993; Hofmann and Eichele, 1994). The precise mechanism by which




Embryonic development involves growth, differentiation, pattern formation, and
morphogenesis. Differentiation is the process whereby cells assume their specialized
functions. Pattern formation is the spatial pattern ofgrowth and differentiation that
results in the shaping (morphogenesis) of an embryo or one of its parts.
Teratogenesis is a term commonly used to denote the advent ofbirth defects
resulting from prenatal exposure to exogenous agents (teratogens). Ofthe agents listed in
the Catalog ofTeratogenic Agents (Shepard, 1995), about thirty are known to produce
malformations in hiunans. Retinoids are listed among these knovm human teratogens.
Among the most widely studied retinoids are tretinoin (eM-trans retinoic acid),
isotretinoin (IS-cw-retinoic acid), and etretinate (an aromatic retinoid sometimes called
acitretin). As oral drugs, these retinoids exhibit very long elimination half-lives in
humans. Detectable levels ofetretinate, for example, have been demonstrated in five of
47 patients more than 2 years after treatment was discontinued (Agnish et. al., 1990). As
a result, the period of time after cessation of therapy during which pregnancy must be
avoided has not yet been reliably determined for all retinoids.
Knowledge of the metabolic fate of therapeutic retinoids is limited. A greater
understanding of retinoid metabolism will lead to safer and more effective uses of these
compounds. The best characterized retinoids are all-trans retinoic acid, IS-cm retinoic
acid, retinaldehyde and retinol. The diverse and dramatic biologic effects of these
retinoids are mediated by the various nuclear retinoid reeeptors and cytoplasmic retinoid
binding proteins which exhibit tissue-specific distribution patterns (Sherman, 1986; Wolf,
1991; Chambon, 1996; de The, 1996).
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These experiments explore the general hypothesis that retinoic acid (RA) non-
specifically promotes differentiation by cells committed to a particular developmental
pathway. Specifically, the question raised is whether biologic factors, capable of
regulating the availability ofRA to its receptors, can thereby control the patterns of
differentiation that drive organogenesis. In this work, the developing chick limb serves as
the experimental model system, and limb-bud outgrowth is the morphogenetic process of
interest. This study explores the idea, that limb-bud outgrowth requires establishing an
environment, in the distal end of the growing limb bud, in which the cells are allowed to
continue, dividing and are prevented from premature differentiation. Specifically, these
experiments ask whether localized expression of a cytoplasmic protein, that selectively
binds RA, may reduce RA availability by promoting RA degradation, and thus locally
constraining RA’s ability to promote differentiation.
II. Literature Review
A. The limb bud as an experimental model
One of the best studied models ofpattern formation in vertebrates is the
morphogenesis of the limb bud (Wolpert, 1978; Javois, 1984). Mesenchymal cells
migrate laterally from the somatic layer of the lateral plate mesoderm and accumulate
under the ectoderm (Balinsky, 1975). As it emerges from the lateral body wall of the
embryo, the limb bud assumes the shape of a dorsoventrally flattened dome. As
outgrowth continues the limb elongates. A narrow ridge ofpseudostratified columnar
epithelium, formed from overlying ectodermal cells, runs along the antero-posterior axis
on the distal rim of the limb bud. This is called the apical ectodermal ridge or AER (Fig.
1) (Saimders, 1948; Saunders, 1977; Riddle and Tabin, 1999).
Signals from the AER stimulate or promote limb outgrowth. As the limb bud
grows, the mitotic rate remains high distally near the AER and steadily declines in the
proximal mesenchyme (Hombruch and Wolpert, 1970; Cooke and Summerbell, 1980).
The limb's elongated profile takes shape through this differential growth along the
proximodistal axis. Removal of the AER causes the limb to stop growing, producing a
truncated limb with distal skeletal deletions (Saunders, 1948; Kosher et al. 1979; Hurle
and Ganan, 1986,1987; Rowe et al. 1982). The extent of limb deletions is determined by
the time ofAER removal. For example, AER removal at chick embryonic stages 19-20
(3-4 days) yields a limb missing all parts distal to the humerus. Subsequent removal
4
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yields increasingly complete limbs with increasingly distally restricted deletions.
Extending the anterior to posterior breadth of the AER leads to a broadening of the limb
bud and the formation ofextra digits (Zwilling, 1955). Grafting a second AER to the
limb bud induces supernumerary distal limb structures (Saunders and Gasseling, 1968;
Zwilling, 1956). Clearly, the AER maintains the differential growth rate while delaying
differentiation in the subridge mesenchyme. One aspect of the mechanism whereby the
AER exerts this effect has recently been elucidated (Niswander and Martin, 1994;
Niswander et al. 1993; Fallon et al. 1994; Cohn et al. 1995; Ohuchi et al. 1997).
Fibroblast growth factors (FGFs) comprise a family ofcytokines whose role in
limb outgrowth and patterning has only recently come to be appreciated (Cohn et al.
1995; Crossely et al. 1996). Isoforms critical to enhancing mesenchymal proliferation
include FGF-2, FGF-4, FGF-8 and FGF-10 (Burgess et al. 1989; Goustin et al. 1986;
Ohuchi et al. 1997). FGF-2 is normally expressed in limb mesenchyme and ectoderm.
When the AER is excised and beads impregnated with FGF-2 or FGF-8 are implanted
along the distal tip, limb outgrowth and skeletogenesis continue (Fallon et al. 1994; Cohn
et al. 1995). Mesenchymal proliferation and limb bud outgrowth are enhanced by FGF-4
in organ cultures and in vivo when the AER has been excised (Niswander and Martin,
1994; Niswander et al. 1993). FGF-4 is expressed by the AER, but is restricted to its
posterior half, and may not accoimt entirely for the AER’s growth-promoting effect.
FGF-8 is expressed throughout the AER and is the best candidate for the AER
proliferation maintenance signal due to its timing, pattern of expression, and its ability to
substitute for an excised AER (Crossely et al. 1996; Vogel et al. 1996). FGF-10, a
Figure 1. Stage 23-24 Chicken Wing Bud. The dark
area is the limb mesenchyme. The apical ectodermal ridge
(AER) appears translucent (arrows). The distal cells are
situated within the arch of the AER, whereas the proximal
cells lie beyond the region of the AER (From Paulsen,
1994).
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newer member of the cytokine family, is expressed by distal limb mesenchyme. It
initiates and maintains limb outgrowth by maintaining the AER and its expression of
FGF-8 (Ohuchi et al. 1997). Although this represents a substantial advance in the
understanding ofAER function, the cellular mechanisms whereby the FGF signals control
proliferation and differentiation remain to be elucidated.
Limb outgrowth is asymmetrical along three main axes: the anterior-posterior (as
in the line between the thumb and the little finger), the dorsal-ventral (as in the line
between the hand's back and palm), and the proximal-distal (as in the line from the
shoulder to the fingertip). These axes are established at different times and by different
mechanisms. Just as the AER appears to regulate pattern formation along the
proximodistal axes, pattern across the anteroposterior axis appears to be specified by a
mesenchymal cell group along the limb bud's posterior margin, referred to as the
polarizing region or zone ofpolarizing activity (ZPA). Although outgrowth along the
limb’s proximodistal axis is the focus of the present research, the possible significance of
retinoic acid as a developmental signal first came to light from studies of anteroposterior
patterning in the limb. Thus this aspect of limb development also merits consideration in
describing the background of this study on proximodistal outgrowth.
When cells from the ZPA are grafted to the anterior margin of another intact wing
bud, the digit pattern is duplicated in mirror image symmetry. The normal digit pattern in
the wing bud is designated 234, with digit 2 being closest to the anterior margin and digit
4 at the posterior margin. After grafting an additional ZPA to the anterior surface of the
wing bud, the pattern then becomes 432234, anterior to posterior (Fig. 2). Thus, the ZPA
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cells can specify a new anteroposterior skeletal pattern in the host limb (Saunders and
Gasseling, 1968; Tickle et al. 1975).
It has been proposed that a signal from the ZPA acts on the mesenchymal cells in
the progress zone (the region of undifferentiated mesenchymal cells at the tip of the limb)
and determines the pattern of structures that develop along the anteroposterior axis of the
wing bud (Tickle et al. 1975; Wolpert, 1978). The graded distribution of a substance
within the limb bud could convey such “positional information.” Thus, cells at different
distances from the source would be exposed to different concentrations of the
morphogenetic signal in their surroundings and would later differentiate accordingly
(Wolpert, 1978). When dX\-trans retinoic acid (RA) is locally applied to the anterior
limb-bud margin on small controlled-release carriers (affinity chromatography beads),
mirror-image duplicated skeletal patterns, like those obtained with ZPA grafts (Fig. 2),
are produced (Tickle et al. 1982; Tickle et al. 1985; Eichele et al. 1985; Thaller and
Eichele, 1987). In addition, it was shown that not only is all-trans-RA endogenous in the
chick limb bud, but it also forms a concentration gradient across the limb bud, with a
high-point in the posterior domain, containing the ZPA (Tickle et al. 1985; Thaller and
Eichele, 1987).
The ZPA-mimicking action ofRA led to the hypothesis that exogenous RA acts
by producing graded positional information across the anterior posterior limb axis and
that RA might be the ZPA signal (Summerbell and Maden, 1990; Tickle, 1991). The
addition of digits to the wing pattern is sequential. Each extra digit can be produced by
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Figure 2. Skeletal Digit Pattern ofChick Wing. Normal chick wing (e) anterior
posterior skeletal digit pattern (234). The supernumerary structures (Q resulting
from grafting retinoic acid soaked beads onto the wing buds ofchick emtnyos were
inmirror image symmetry ofthe normal digit pattern (432234). FromM.Maden,
1994, Nutrition Reviews, 52.
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either increasing RA concentration (up to 25 nM) or by increasing the length of exposure
(up to 18 hours) with the appropriate dose ofRA (Tickle et al. 1985; Eichele et al. 1985;
Tickle, 1991). It was later discovered that another isoform ofRA, 3,4 didehydroretinoic
acid (ddRA) is present throughout the limb at concentrations six-fold higher than RA
(Thaller and Eichele, 1990). The fact that ddRA proved to have limb-duplicating ability
identical to that ofRA ruled out RA as the prospective antero-posterior morphogen in the
limb (Thaller and Eichele, 1990).
There is evidence that a gene, Sonic hedgehog (Shh), selectively expressed by
cells of the ZPA, encodes a protein that serves as the ZPA signal (Wolpert, 1978; Riddle
et al. 1993). Pellets ofnon-ZPA cells, transfected with the Shh gene and grafted into the
anterior region of the limb bud, were shown to induce pattern duplication in a
concentration- and position-dependent manner (Riddle et al. 1993). Beads soaked in RA
and implanted to the anterior margin induce Shh expression in the mesenchyme just distal
to the bead after 24 hours. Only the cells between the bead and the AER produce Shh
protein, thereby indicating that the AER signal may prepare the cells to respond
appropriately to RA (Riddle et al. 1993). Shh expression follows in a dose-dependent
manner when beads soaked in physiological (10 yug/ml) or pharmacological (330 //g/ml)
doses of all-trans RA were grafted into distal anterior limb tissue (Helms et al. 1994).
The precise role ofRA in normal limb development remains unclear. The
apparent ability of the AER to regulate the response of the distal cells to RA is of
particular interest in this study. Since RA and its precursor are present in the limb, but
only cells under the AER are capable of responding to RA, the AER appears to have a
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crucial role in the interpretation of the RA signal during normal morphogenesis. How
this priming occurs and whether RA is involved are questions of interest. The
implication is that RA remains a candidate for an important role in the regulation of
pattern formation by mediating interactions between the AER and the ZPA.
B. Teratogenic effects of retinoids on limb skeletal patterning.
The importance ofRA in mediating morphogenetic signals is imderscored by its
teratogenicity. A variety of retinoid-containing drugs (eg., tretinoin, isotretinoin,
etretinate, acitretin, etc.) present a clear developmental risk for the limb (Teratology
Position Paper, 1987). While dietary retinoids (generally, in the form of retinol) are
required for normal growth, pharmacologic levels of retinoids are potent teratogenic
agents, causing severe congenital malformations in vertebrates (Cohlan et al. 1953;
Means and Gudas, 1995).
Systemic treatment ofpregnant mice with RA has teratogenic effects on the
embryonic limbs, including the absence of distal cartilaginous elements (Kochhar, 1973;
Wood et al. 1996). This ability to cause distal limb reduction anomalies that resemble the
outcome of excising the AER is striking and well known (Kochhar, 1973; Kwasigroch
and Kochhar, 1980; Lammer et al. 1985; Rizzo et al. 1991). The teratogenic effects of
retinoids on the limb are perhaps best known in mice where the period of sensitivity is
between the eleventh and twelfth day ofgestation and corresponds well to that during
which the AER is present (Kwasigroch and Kochhar, 1980). Treating pregnant mice with
RA at progressively later times during the sensitive period causes limb reduction defects
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in their offspring at progressively more distal levels (Kwasigroch and Kochhar, 1980).
This effect resembles that obtained with chick embryos when their AERs were excised at
progressively later times (Saunders, 1948; Summerbell, 1974), suggesting that retinoids,
at teratogenic doses, chemically excise the AER (Kwasigroch and Kochhar, 1980). The
apparent ability of exogenous retinoids to interfere with the fundamental role of the AER
in limb-bud outgrowth, further suggests that the AER’s growth-promoting effect operates
through a mechanism involving regulating the effects ofRA on the nearby cells. The
present studies are designed to provide some insight into our limited knowledge about the
complex interaction between the AER, the mechanism of retinoid teratogenicity in the
limb, and its relationship to normal AER function.
C. Effects of retinoids on limb cells in culture
Analysis of the mechanism ofRA action, in normal and aberrant limb
development in vivo, is complicated by the rapid environmental changes occurring in the
developing limb. A cell culture system in which RA’s effects can be explored using a
serum-free medium has been developed by Paulsen (Paulsen and Solursh, 1988).
Paulsen’s defined medium (PDM) consists of a 1:1 mixture ofHam’s F12 nutrient
mixture (F12) and Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with
hydrocortisone, insulin, chicken transferrin, ascorbic acid and antibiotics (see Materials
and Methods). Chick wing-bud mesenchymal cells cultured in PDM show enhanced
chondrogenesis when treated with RA at 5 ng/ml (Paulsen et al. 1988). In PDM, RA
concentrations above 10 ng/ml cause a dose-dependent inhibition of chondrogenesis
13
(cartilage differentiation) whereas for cultures grown in standard serum-containing
medium, RA inhibits chodrogenesis at all concentrations (Paulsen et al. 1988). PDM is
particularly useful for such studies because it does not contain the unknown amounts of
RA and other retinoids typically present in serum supplements.
RA effects on limb chondrogenesis in serum-free cultures have been shown to be
region-dependent (Paulsen et al. 1994). Cultures ofmesenchyme isolated from different
proximodistal regions of stage 21-22 and stage 23-24 chick wing-buds exhibited RA-
mediated stimulation ofboth proliferation and chondrogenesis. Less stimulation was
seen in cultures of the proximal limb regions (Paulsen et al. 1994). These findings
support the ability of the AER to modulate the way distal limb mesenchymal cells
respond to RA and the contention that RA concentrations alone cannot provide the
positional information required for organogenesis. Thus, while RA can dramatically
affect cell behaviors that have a pivotal role in skeletal morphogenesis, the cellular
mechanisms whereby these effects are carried out are not clearly imderstood.
D. Retinoid metabolism and chemistry
Vitamin A exists in multiple oxidation states (e.g., alcohol, aldehyde, and acid)
which carry out its various functions. Retinol (alcohol), retinal (aldehyde), and retinoic
acid (acid) are among the best studied retinoids.
The basic metabolic pathway from retinol to retinoic acid starts with mobilization
of cellular stores of retinyl esters to provide retinol (Fig. 3). Then retinol is reversibly
dehydrogenated to form retinal, which may be irreversibly oxidized to produce retinoic
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acid. Based on the works ofPosch et al. (1991,1992), and Napoli et al. (1991), it is
believed that several enzymes in this pathway function through recognition of retinoid
binding proteins, particularly CRABP (see Section G.).
1. Retinoid digestion and storage
In adults, dietary vitamin A is derived from P-carotene (fruits and vegetables) or
retinyl esters (egg yolks, butter, whole milk products, liver and fish liver oils).
Carotenoids are the red and yellow pigments produced by a variety ofplants. The
pigments with the greatest vitamin A activity (in order ofdecreasing activity) are P-, a-,
and y-carotene (Olson, 1988; Zeng, Furr and Olson,1992). Compared to P- carotene, the
a- and y-carotenes exhibit activities ranging from 50% to 54% and 42% to 50%,
respectively. P- carotene contains the carbon and ring structure for two molecules of
retinol (vitamin) A and is consequentially converted to retinaldehyde by intestinal
enzymes during absorption (Fig. 3). Pepsin and proteolytic enzymes (stomach and small
intestine, respectively) release carotenes and retinyl esters (RE) from endogenous proteins
in foods prior to intestinal absorption (Simpson and Chichester, 1981).
Dietary fats and secreted bile acids facilitate absorption of the released
carotenoids and RE, which are solubilized into micellar solutions. Once absorbed fi-om
the intestinal lumen, hydrolysis of retinyl esters and any carotenoid by various esterases
occurs at the same time other fatty ester compoimds (triglycerides, phospholipids and
cholesterol esters) are being hydrolyzed by pancreatic enzymes because these enzymes
play a very important role in providing a proper physicochemical environment in the
intestinal lumen for vitamin A absorption (Ganguly, 1989). Ong (1993) demonstrated
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that cholesterol ester hydrolase or pancreatic lipase is responsible for the hydrolysis of
short-chain esters, whereas activity against long chain retinyl ester (RE) is intrinsic to the
brush border of the intestinal lining. The dietary RE are hydrolyzed in the lumen to
liberate retinol prior to micellar absorption by the enterocytes.
The biological transformation of carotene to retinol is a rather complex process
(Ganguly, 1989). Two theories have been proposed for the mechanism of conversion;
one suggests an asymmetrical or random cleavage, while the other supports cleavage at
the central double bond. Several other pathways for carotenoid metabolism are being
explored (Zeng, Furr, and Olson, 1992; Ong, 1993). Within the intestinal mucosal cell
(enterocyte), however, the product of enzymatic, oxidative carotene cleavage is s\\-trans-
retinal. Retinal can then be reduced to retinol by a non-specific aldehyde reductase
which exerts activity on short or medium chain aldehydes. However, within the
enterocyte, retinal is boimd by cellular retinol binding protein, type two (CRBP-II). This
protein is formed in adult human small intestine (Ong and Page, 1987). The specific site
ofCRBP-II activity is the enterocyte, the most active point of vitamin A absorption. This
protein binds both all-/ra/ts-retinol and all-/ra«j-retinal with equal affinity (Ong, 1993).
Retinal bound to CRBP-II is readily reduced to retinol by an aldehyde
dehydrogenase, a microsomal enzyme requiriingNADH as a coenzyme (Wolf, 1991;
Ong, 1993). The retinol fi-om dietary RE and the retinol derived from P-carotene bind to
CRBP-II and follow the same metabolic pathways. Retinol boimd to CRBP-II is
esterified with long chain fatty acids as the final metabolic step in the small intestine
enterocyte. Palmitate, stearate, oleate, and linoleate, in the approximate yet constant
16
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Figure 3. Retinoid synthesis from p-carotene. P-carotene is amain dietary
source for retinoids. Once ingested it is enzymatically converted to retinaldehyde.
There are subsequent enzymatic and chemical conversions for transport (retinol),
storage (retinyl esters) and biologic acitivators (retinoic acid and isomers).
17
proportions of 8:4;2:1, account for the majority of esterified fatty acids. Esterification is
also performed by microsomal enzymes, acyl-CoA:retinol acyl transferase (ARAT,
which acts on unbound or free retinol) and phosphatidylcholine or lecithin-retinol acyl
transferase (LRAT, which acts on the retinol-CRBP-II complex) (Ong, 1993). The
resulting RE is then incorporated into the lipid core of chylomicrons. RE, incorproated
into chylomicrons, pass into the lymphatic vascular system and are transported via blood
to hepatocytes (Goodman, Huang, and Shiratori, 1965; Huang and Goodman, 1965).
The liver takes up dietary retinoid from chylomicron retinyl esters and stores most
of the body's retinoid reserves as retinyl esters in lipid droplets (Goodman, Huang, and
Shiratori, 1965; Zachman, Singer, and Olson, 1966; Zachman et al., 1966; Goodman and
Blaner, 1984). Actually, these RE vmdergo further hydrolysis and reesterification before
storage. Two types of liver cells are involved in hepatic metabolism of retinoids:
parenchymal cells (hepatocytes), for chylomicron and retinyl ester uptake (Blomhoff, et.
al., 1982; Goodman, 1984), and stellate cells, for RE storage and metabolism in the liver
(Blomhoff, et. al., 1982; Blomhoff, et. al., 1984; Kato, et.. al., 1984; Hendriks, et. al.,
1985; Blaner, et. al., 1985).
RE reaching the liver is hydrolyzed to fi’ee retinol in the parenchymal cells by
retinyl palmitate hydrolase and ARAT (Blomhoff, et. al., 1985; Blaner, et. al., 1985). The
resulting retinol can combine with either cellular retinol binding protein (CRBP), for
intercellular transport, or retinol binding protein (RBP), for serum transport. Present data
offer two possible routes by which retinoid transfer occurs between parenchymal and
stellate cells: 1) CRBP may aid in the transport of retinol fi'om parenchymal cells to
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stellate cells, in retinyl ester storage, or both (Wolf, 1991; Ong, et. al., 1988); and 2) RBP
bound to newly synthesized retinol and secreted by parenchymal cells may deliver retinol
to stellate cells via RBP receptors on the target cells (Blomhoff, et. al., 1985; Gjoen, et.
al., 1987). More insight about the retinoid transfer between the parenchymal and stellate
cells may be gained by obtaining more information about the origin and destination of the
binding proteins (Blomhoff, 1987). It is worth noting here that the cytoplasmic retinol
binding proteins (CRBPs), which are known to be instrumental in retinol (ROH)
metabolism, belong to the same family ofproteins as the cytoplasmic RA-binding
proteins (CRABPs). The striking structural similarity of these proteins suggests there
may be some functional similarities as well. While this cannot be construed as proof, it is
certainly consistent with a role for CRABP in regulating RA metabolism.
2. Mobilization of stored retinoids
When there is a metabolic need for vitamin A, stored RE is hydrolyzed to form
free retinol. The liver regulates the release of retinol into the circulation in response to
the demands of tissues that utilize vitamin A. Retinol must be mobilized from its storage
depot in stellate cells to the plasma retinol-RBP pool. Retinol is secreted from liver in
association with RBP and circulates as the retinol-RBP-transthyretin complex to
peripheral tissues (Ross, 1993c; Creek et al. 1993). Two mechanisms have been
proposed for retinol mobilization from the liver. Evidence that cultured hepatocytes can
synthesize RBP and secrete retinol-RBP has led to the hypothesis that they are the
exclusive site ofmobilization (Rask, 1983; Ronne, 1983). Alternatively, studies have
shown that isolated stellate cells also contain RBP and that cultured stellate cells secrete
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retinol bound to RBP (Blomhoff et al. 1985; Blaner et al. 1985; Yamada, 1987; Blomhoff
etal. 1990).
In mammals, retinoids cross the placenta from the maternal to fetal circulation,
undergoing some chemical modifications in the process. In birds, retinyl esters are stored
in the yolk and liberated during development by the surrounding endodermal cells (Dong
and Zile, 1995). These cells serve as the predecessors for the enterocytes, hepatocytes
and stellate cells (endodermally derived cells) so important in postnatal retinoid
absorption and metabolism. Yolk-derived retinoids are absorbed by the endodermal cells
lining the yolk sac (Dong and Zile, 1995). They diffuse through the embryo of early
stages and are distributed by the circulatory system once it develops.
E. Retinoid metabolism in embryonic cells
Retinoic acid (RA) has been shown to regulate patterns ofcellular differentiation
in developing embryos. When exogenous RA is applied to the early limb bud, it induces
digit pattern duplications or skeletal truncation in a dose-, stage-, time-, and position-
dependent manner (Tickle et al. 1982; Summerbell, 1983; Tickle et al. 1985; Eichele et
al. 1985; Thaller and Eichele, 1988). Retinoids normally present in the early chick limb
bud were determined by Thaller and Eichele (1987) to include all-/ra/i5-retinoic acid
(RA), all-rra«5-retinol (ROH), 4-hydroxyretinol (4-hROH), all-Zraw^-retinal (RAL), 3,4-
didehydoretinoic acid (ddRA; Thaller and Eichele, 1990) and 9-cis RA (Heyman et al.
1992; Levin et al. 1992). The endogenous concentration ofROH in the limb is 25 times
that ofRA and 4 times that ofddRA, suggesting that ROH serves as a precursor for RA.
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The low levels ofRAL suggest that this compound serves as an intermediary metabolite
(Thaller and Eichele, 1988). Studies using radiolabeled precursors showed that retinoid
metabolites appearing in the limb tissues are generated locally within the limb, and not
produced elsewhere (e.g., the liver) and then transported to the limb by the blood stream.
This finding supports the view that retinoids are local chemical mediators of
developmental processes. It also provides a simple mechanism to generate biologically
active RA from the abundant ROH precursor in a controlled manner (Thaller and Eichele,
1988).
F9 mouse embryonal carcinoma cells respond to RA by differentiating into
primitive endoderm, an extraembryonic epithelial-like cell type, which progresses to
become visceral endoderm (reviewed by De Luca, 1991). Retinol has been estimated to
be 10-15% as active as RA in F9 cells. This lower potency ofROH is attributable to a
requirement for conversion to RA, although at a very low rate, for its activity (Williams
and Napoli, 1985). Retinol metabolism in F9 cells was found to be mainly esterification
to retinyl palmitate, with significantly lower levels ofpolar metabolites identified as RA
(Williams and Napoli, 1985; Gubler and Sherman, 1985).
On the other hand, in the presence ofketoconazole (an inhibitor of P450
metabolism), F9 teratocarcinoma stem cells readily metabolize all-/ra«5-RA to even more
polar compounds, mainly 4-oxo-RA and 4-hydroxy-RA (Williams and Napoli, 1985;
Gubler and Sherman, 1985; Boylan and Gudas, 1992). This ability to oxidize RA in the
presence of an inhibitor ofoxidation by cytochrome P450 (a family ofwidely distributed
dehydrogenases) suggests that there must be alternative enzymes or pathways for RA
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production. A proposed scheme for RA metabolism is that it is first converted to 4-
hydroxy-RA and further oxidized to 4-oxo-RA and subsequently to other, more polar,
metabolites (Roberts, 1981). However, Gubler and Sherman (1985) and Williams and
Napoli (1985) in independent studies were able to identify only 4-hydroxy-RA as a RA
metabolite in F9 cells, while no significant amounts of4-oxo-RA, 13-cw-RA, or retinoyl
glucuronide were observed.
Although Thaller and Eichele (1987, 1988,1990) have explored ROH metabolism
in chick limb mesenchyme, nothing is known about RA metabolism in this tissue. The
presence of significant amounts of ddRA and RA throughout the limb indicate that while
oxidation of retinol to RA occurs in the limb, there is no pattern ofRA production that
can account for the known patterns ofRA activity in the limb. This suggests that factors
regulating the pattern ofRA degradation or its access to nuclear RA receptors are
responsible for the region-dependent differences in its effects. This view is further
supported by evidence that cells isolated from different limb-bud regions respond
differently to identical concentrations ofRA (Paulsen et al. 1993,1994). Clearly this
issue is important in understanding the mechanism of retinoid effects on limb
development.
Of corollary significance in embryonic metabolism of retinoids is the metabolism
and transfer of retinoids through the placenta. RA administered to pregnant women and
animals has caused severe congenital abnormalities in the neonate (Geelen, 1979;
Lammer et al. 1985; Rosa et al. 1986; Agnish et. al., 1990). Satre et al. (1992), working
with mice, found that endogenous levels of retinoids during early organogenesis were 8-
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fold higher in the placenta than in the embryo, whereas by mid-organogenesis the retinoid
content of the embryo was 4-fold greater than that of the placenta. Creech-Kraft et al.
(1991; 1993) examined the endogenous levels of retinoids in various human embryonic
and fetal tissues at various stages of gestation. They found that severed high doses (100
mg/kg) of 13-cw-RA (isotretinoin) in pregnant mice were more embryotoxic than a single
administration of the same dose. They also determined that the plasmametabolites of 13-
cis-RA after 3 treatments (100 mg/kg) were the polar forms of vitamin A: 4-oxo-all-
trans-RA, 4-oxo-13-c/j-RA, 13-cw-retinoyl-P-glucuronide (H-cw-RAG), and d\\-trans-
RA. The 4-0X0 metabolites were foimd in the embryo in such low concentrations after
the final dose that they were the unlikely source of teratogenesis. Although the
glucuronide metabolites predominated in the placenta, they are non-teratogenic (Gunning
et al. 1988,1993), yet biologically active products of detoxification (Swanson et al. 1981;
Zile et al. 1982; Barua and Olson, 1986). Furthermore, transfer of the glucuronides to the
embryo was very inefficient compared to all-P*a«^-RA, which was 2- to 3-fold higher in
the placenta than in the plasma while maintaining a 100-fold efficiency in transfer to the
embryo. These observations suggest that the placenta sequesters retinoid metabolites and
allows cis/trans isomerization, that RA is responsible formost of the effects described in
the embryo and that further oxidation or glucuronidation ofRA can limit its
developmental effects. Thus typical types ofRA metabolism appear to inactivate this
potent promoter of cell differentiation. Therefore, it seems reasonable to speculate that
the early low embryonic and high placental levels suggest that the placenta may sequester
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retinoids early on to allow rapid growth of expanding stem cell populations and to
prevent premature differentiation ofembryonic tissues.
F. RA modulation of gene expression via nuclear retinoid receptors
The discovery of the nuclear RA receptors (RARs) and the orphan retinoid
receptors (RXRs) provided a clearer understanding ofthe molecular mechanisms linking
RA signals to the control of gene expression (Evans, 1988; Mangelsdorf et al. 1990).
Analysis of the amino acid sequence and domain structure demonstrated that each
belongs to the steroid/thyroid hormone receptor superfamily ofproteins. These nuclear
receptors act as transcriptional enhancer factors (Green and Chambon, 1988). RARs
appear to regulate gene transcription in a ligand-dependent fashion through binding to
specific DNA sequences, generally located upstream of the promoter of target genes
(Umesono et al. 1988). The discovery of specific nuclear receptors for RA provided
strong evidence that the marked effects ofRA on morphogenesis resulted from the
activation of developmentally controlled genes. Three classes ofmammalian RAR genes
have been identified. The corresponding receptors, RAR-a (Petkovich et al. 1987), RAR-
P (Brand et al. 1988), and RAR-y (Krust et al. 1989), differ in their binding to RA-
responsive elements of target genes and in their affinity for retinoids. The RA response
elements (RAREs) are defined as the minimal DNA sequences required to bind the RA
receptors with high affinity. Each receptor subtype has a number of isoforms; seven for
RAR-a (Leroy et al. 1991), three for RAR-P (Zelent et al. 1991), and seven for RAR-y
(Kastner et al. 1990). Analysis of the distribution ofRAR-a and RAR-y in the limb bud
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by in situ hybridization did not show the graded distributions one might expect were their
expression levels responsible for regulating patterns ofdifferentiation (Dolle, Ruberte, et
al. 1989), although RAR-y may be involved in RA-mediated inhibition of chondrogenesis
by committed chondrocytes and promotion ofskin differentiation (Dolle, Ruberte, et al.
1989). On the other hand, certain RAR-6 transcripts (RAR-P2) are restricted to the most
proximal portion of the limb and application ofRA directly to the chick wing bud
increases RAR-Bj expression distally (Rowe et al. 1991).
The RXRs have less affinity for all-tranj-RA than do the RARs (Mangelsdorf et
al. 1990). RXR a, p, and y subtypes have been identified in mouse embryos
(Mangelsdorf et al. 1992). In adult humans, RXR-a is highly expressed in the liver,
which is a major site ofvitamin A (retinol) storage, metabolism, and mobilization. RXR-
a may regulate vitamin A metabolism (Mangelsdorf et al. 1990). RXRs bind selectively
to 9-cw-RA and can be activated by all-Zran^-RA only at higher concentrations, possibly
due to the isomerization of all-Zram-RA to 9-cw-RA (Heyman et al. 1992).
Still despite their number, variety, and different effects on gene expression, the
patterns of expression of these receptors in the developing limb alone cannot account for
RA’s region-specific effects on patterns of differentiation (Paulsen, 1994).
G. The Role of Intracellular Proteins in Mediating RA Effects.
Retinoid effects are mediated by two types ofproteins: the cellular retinoid
binding proteins and the nuclear RA receptors. In the cytoplasm, two main types of
binding proteins are identified as mediators of retinoid activity: 1) the cellular retinol
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binding proteins type I and II (CRBP-I and CRBP-II) and 2) the cellular retinoic acid
binding proteins type I and II (CRABP-I and CRABP-II) (Ong et al. 1983; Ong, 1985;
Eriksson et al. 1984; Kato et al. 1987). These low molecular weight proteins have close
amino acid sequence homology yet exhibit high specificity for respective binding ofROH
or RA. The CRABPs belong to a superfamily of fatty acid binding proteins that includes
the CRBPs and RBP. The members of this family bind hydrophobic ligands and have a
molecular weight between 18-21 kD (Matarese et al. 1989). Chicken CRABP-I (M.W. 15
kD) and CRABP-II (M.W. 15.7 kD) share 83% sequence homology (Venepally et al.
1996; Fiorella et al. 1993; Sanquer et al. 1994; Maden, personal communications).
CRABPI has a dissociation constant (Kj) for RA of4-10 nM, whereas CRABP-II has a
3-fold lower affinity for RA than CRABP-I with an apparent of about 50-70 nM (Ong
and Chytil, 1975; Ross et al. 1980; Fiorella and Napoli, 1991,1993; Sanquer et al. 1994).
Less is known about the role ofCRABP in mediating RA’s effects than about
CRBP’s role in ROH metabolism. CRABP may generally serve as a carrier/shuttle to
deliver RA, its ligand, to specific nuclear binding sites (Takase et al. 1986; Maden et al.
1988). When RA is provided in a complex with CRABP, but not when provided as free
(unbound) RA, it was shown to bind specifically to both nuclei and chromatin (Ong and
Chytil, 1975; Takase et al. 1986).
Another possible role ofCRABP involves facilitating RA metabolism and
degradation. Once RA has entered the cytoplasm it may form a complex with CRABP,
which then directs the RA to an enzyme system responsible for RA metabolism (Boylan
and Gudas, 1992). Compared to normal F9 cells, CRABP-I-overexpressing F9 cells
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degraded RA to more polar forms at a higher rate (BoyIan and Gudas, 1992). Thus,
CRABP could limit RA interaction with nuclear receptors by promoting cytoplasmic
metabolism/degradation (Napoli et al. 1991; Boylan and Gudas, 1991). CRABP may
sequester RA in the cytoplasm and prevent it from interacting with the nuclear receptors (
Maden et al. 1988; Gustafson et al. 1993). RA induction studies ^vith F9 teratocarcinoma
cells showed that CRABP-1 over expression inhibits RA-induced differentiation and
activation of reporter genes with RA response elements (Boylan and Gudas, 1991).
Metabolism or degradation ofRA would regulate the amount ofRA reaching the nuclear
RA receptors (RARs). In addition, CRABP may regulate cellular responses by binding
RA at the site of synthesis in the cytoplasm and delivering it to the nucleus for association
with a nuclear RAR without further isomerization (Petkovich et al. 1987; Giguere et al.
1987).
In the chick limb bud, CRABP exhibits a spatial distribution along the
anteroposterior axis reciprocal to the concentration gradient ofRA (Maden et al. 1988).
Recall that CRABP has a high affinity for RA. This opposing distribution of binding
protein to ligand could actually steepen the gradient of available RA and could yield a
gradient of ddRA as well. This would be due to the sequestration of available RA by
CRABP so that the more anterior region would exhibit a lower concentration ofavailable
RA, thereby allowing differential regulation ofgene transcription due to spatial
modulation of the morphogenetic information (Maden et al. 1988). Based on this, it has
been suggested that CRABP not only regulates the intracellular concentration ofavailable
RA, but also may compete with nuclear receptors for available RA (Maden et al. 1988).
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H. CRABP Distribution in the limb bud
The current information available on CRABP distribution in embryonic systems
indicates some conflicting results (reviewed by Paulsen, 1994). Immunohistochemical
and in situ hybridization studies have elucidated the pattern ofCRABP expression in the
developing limb ofchick and rodent embryos (Maden et al. 1988,1990; Hatori et al.
1991; Dolle, Ruberte, et al. 1989; Dolle, Izpisua-Belmonte, et al. 1989; Perez-Castro et al.
1989; Ruberte et al. 1992; Gustafson et al. 1993). These studies revealed differential
expression of the CRABP isoforms (CRABP-I and CRABP-II) in rodents when compared
to the CRABP isoforms expressed in the chick. Mouse CRABP-I riboprobe (Ruberte et
al. 1992) and rabbit anti mouse CRABP-I antibody (Gustafson et al. 1993) clearly
delineated enhanced CRABP-I expression in the distal limb region of 10-day postcoital
embryonic mice. These results correspond to an earlier immimohistochemical study of
CRABP expression in early (3-4 day) chick embryo. Using rabbit anti rat CRABP
antibody, it was demonstrated that CRABP is also located in the distal region ofboth
stages studied as well as along the periphery of the proximal region in the later stage (4
day) chick limb bud (Maden et al. 1988).
However, there is some confusion regarding the role or even existence of chicken
CRABP-II (Kitamoto et al. 1988). A cDNA probe for chicken CRABP-I demonstrated an
86% sequence homology over a 194 base pair overlap for mouse CRABP-I and a 71%
homology over a 297 base pair overlap for mouse CRABP-II (Vaessen et al. 1990). No
selective cDNA probes for chicken CRABP-II have yet been reported. Although a
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chicken CRABP-II protein (Kitamoto et al. 1988) has been described, there are
indications that its structure and distribution pattern are similar to mouse CRABP-I and
distinct from rodent CRABP-II (Kitamoto et al. 1989; Miyagawa-Tomita et al. 1992).
Therefore, it remains possible that only one CRABP gene exists in chick embryos
(Vaessen et al. 1990) and that alternative mRNA splicing or post-translational
modification may have given rise to the additional isoform noted by Kitamoto et al.
(1988) in non-denaturing gels.
I. Possible Role ofCRABP Distribution in Mediating RA effects
During limb morphogenesis, skeletal pattern appears to be established by cells
acquiring a “positional value” dictated by their position in the developing limb. The
resulting integration of the signals specific to that position leads to the appropriate pattern
of gene expression and, consequently, of tissue differentiation (reviewed by Wolpert,
1978). The presence ofCRABP transcripts in structures known to be targets of retinoid
teratogenesis (Maden et al. 1988, 1989; Dolle, Ruberte, et al. 1989; Dolle, Izpisua-
Belmonte, et al. 1989; Vaessen et al. 1990; Ruberte et al. 1992) suggests that these cells
strictly regulate the amount ofRA signal reaching their nuclei during normal
development by expressing higher levels ofCRABP. The fact that there is asymmetric
expression ofCRABP in the limb raises questions regarding the possibility of a related
pattern ofRA metabolism. Do such patterns exist? How do they arise and how are they
regulated during limb morphogenesis? These questions could be explained by exploring
the relationship between the pattern ofCRABP distribution in the limb and the type and
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distribution ofRA metabolites in the limb, and by examining the RA metabolites
produced in vitro by cells isolated from different limb regions.
There is evidence that RA affects pattern formation in the embryonic chick limb.
There is also evidence that CRABP can modulate RA metabolism and distribution in the
developing limb. Factors thatmodulate the pattern ofRA distribution and activity in the
limb could thus be very important regulators of limb development and may determine the
skeletal pattern in the limb. An in vitro model system has been developed to help
pursue the role of retinoids in normal limb development. To explore the hypothesis that
RA metabolism may be regulated by the pattern ofCRABP expression in different
regions at various stages of limb outgrowth, extracts from cultured cells from the
proximal and distal regions of stages 21-22,23-24, and 25-26 chick embryo limbs were
analyzed by HPLC to identify spatiotemporal patterns in RA metabolism. CRABP
expression and distribution in these limb regions were examined using Western blot
analysis to determine whether there are stable stage and region related differences. The
correlations revealed in these studies support a relationship between CRABP expression
and RA metabolism. Further analysis could provide an avenue toward understanding the
precise mechanism whereby retinoids influence limb development and other
developmental processes.
III. Materials and Methods
A. Materials
Fertile White Leghorn chicken eggs were obtained from HY-Line Poultry
(Newborn, GA) or Centurion Poultry, Inc. (Cartersville, GA) and incubated in a
Petersime Model 01 rotating incubator to provide limb buds from embryos at the desired
stages (Hamburger and Hamilton, 1951). A\\-trans retinol; dXl-trans- and 13-cw-RA; all-
tram- and 13-c/s-retinaldehyde; 4-oxo- and 4-hydroxy-RA; 5,6-monoepoxy RA were
obtained in purified form through Hoffman-LaRoche (New Jersey) or through Sigma
Chemical Company (St. Louis, Missouri). 5,6-monoepoxy RA was a gift from Dr. A.
Barua (Iowa State University, Ames, Iowa) and 9-cis RA was generously provided by
Ligand Pharmaceuticals (San Diego). [^H]Retinoic acid was purchased from DuPont-
NEN. HPLC grade solvents (acetonitrile, acetic acid, hexane, ethylacetate and
methylacetate) were purchased from Baxter Diagnostics (Stone Mountain, GA).
Chromatographic separation and preparation of the retinoids was performed using a
Whatman Partisil ODS-2 reversed-phase column (250mm x 4.6nim; Whatman
International Ltd., Maidstone, England) on a Waters 625 Biocompatible Gradient HPLC
Unit (Milford, MA). Liquid scintillation coimting was executed in a Beckman LS 5801
Liquid Scintillation Coimter using BioSafell counting cocktail (Research Products
International, Mount Prospect, IL). The polyclonal rabbit anti-hamster CRABP antibody
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was a gift from Dr. Joseph Napoli (SUNY, Buffalo,NY) (Hatori et al. 1991). cDNA
(~300 bp and ~700 bp) probes for chicken CRABP-I were gifts fi’om Dr. Marie Josee
Vaessen, Erasmus University, the Netherlands (Vaessen et al. 1990) and from Dr. Susan
Smith, University ofWisconsin, respectively.
B, Establishing the cell culture system
Fertile eggs were incubated for 95 hours to obtain stage 21-22 embryos, 103 hours
for stage 23-24 embryos and 110 hours for stage 25-26 embryos (Hamburger and
Hamilton, 1951). The resultant embryos were collected or harvested from the eggs and
placed in cold Tyrodes buffered saline solution (Sigma) and staged prior to use. Once the
embryos were decapitated and freed from their membranes, the wing buds were removed
and pooled in cold Tyrodes according to stage. The distal tips comprised the distal 250 to
300 pm of each limb bud as measured on a stage micrometer. Then the remaining
proximal mesenchyme was removed from the body wall. The isolated mesenchyme
segments were pooled in sterile 35 mm glass culture plates containing approximately 10
ml cold Tyrodes buffer.
Pooled limb regions were dissociated using trypsin-collagenase (0.1% tiypsin
(1:250, Difco, Detroit, MI) +0.1% CLS-1 collagenase (Worthington Biochemical
Corporation, Freehold, N.J.) in Ca^^, Mg^^ free Tyrodes solution containing 10% heat
inactivated chicken serum (HyClone Laboratories). The resulting suspension was passed
through a nylon mesh filter to remove any cell aggregates and ectodermal fragments,
washed twice with F12/DMEM (Cellgro, Fisher Scientific), pelleted at 600 x g for 6
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minutes in a table top clinical centrifuge, and resuspended in Paulsen’s defined medium
(PDM; F12/DMEM, 1:1 supplemented with 100 nM hydrocortisone [Sigma], 5 pg/ml
insulin [Collaborative Research, Bedford, MA], 5 pg/ml chicken transferrin [Sigma], 50
pg/ml ascorbic acid [Sigma] and antibiotics [penicillin-streptomycin and fungizone,
GIBCO]) (Paulsen and Solursh, 1988). Cells were counted on a hemacytometer and the
cell density adjusted to 2.5 x 10^ cells/ml.
Experimental cultures for each stage and region were established in 10 X 75 mm
borosilicate glass culture tubes (Kimax), each ofwhich received a 50 pi aliquot of the
appropriate cell suspension (1.25 x 10® cells). Cell-free control cultures were established
set up in identical tubes, containing the same reaction components (except the cells), and
were incubated along with the experimental cultures for each run.
C. Retinoid metabolism studies
1. Experimental cultures
Physiologic (7.5ng/ml) and pharmacologic (136.36 ng/ml) doses ofRA were
delivered to triplicate cultures of each stage and region. Each dose consisted of
radiolabeled RA ( [11,12-^H(N)]-RA, 49.2 Ci/mmol (S.A.), 7.5 ng/ml, 300,000 dpm per
culture,), the pharmacologic dose was supplemented with appropriate amounts ofcold
RA to achieve the required concentration without increasing the radioactive content
(Equation 1). Incubation was brief (1 hour) in a warm water bath in a tissue culture
incubator (37°C, 5% CO2, humidified atmosphere) to allow detectable metabolism. These
33
and the following steps were performed in the dark or under dim or gold-filtered light to
minimize photochemical degradation of the retinoids.
The mixture of radiolabeled and cold RA was combined with an appropriate
volume ofPDM so that the final concentration within the cultures was equivalent to
either a pharmacologic or physiologic dose of substrate (Equation 1). The substrate was
combined with PDM no more than one hour prior to treating the cultmes in order to limit
non-enzymatic degradation and oxidation. This was called the substrate mixture and was
kept on ice until use. The substrate mixture was delivered in 5/.^l aliquots to the samples
via a 20yul Hamilton syringe. The incubation mixture in each test tube consisted of a total
volume of 55jul including 50 pi cells and media and 5 pi ofRA. After the incubation
period of 1 hour, experimental and control tubes were carefully removed from incubator
and placed on ice to inhibit further metabolism or chemical degradation.
2. Sample extraction for metabolism studies
During the extraction procedures all tubes were kept on ice. Extraction buffers
were added to the reaction tubes in the following order and vortexed each time, 300 yuL
retinoid stabilizing buffer (RSB, Thaller and Eichele, 1988), 100/uL 0.2N HCl in
methanol, 20/uL ethanol containing RA standards (13-c/s-RA, 9-c«-RA, all-/ra«j’-RA, 4-
oxo-RA, and A-hydroxy-KK) at Ing/yuL each. The samples were then capped with foil-
lined corks and vortexed vigorously for 30 seconds. Next, 300ywL of hexane was added
to the samples and vortexed again for 30 seconds. The samples were centrifuged at 500
X g for 10 minutes at 4°C and then stored overnight at -80° C to facilitate phase
separation.
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The tubes, containing the hexane extract and frozen aqueous phase, were placed
on dry ice to facilitate the transfer of hexane by glass pipette to glass 3 cc luer lock
syringes (Becton-Dickson) equipped with LI3 minispike PVDF 0.2 yum acrodisc filters
(Gelman Sciences). The hexane extracts were filtered into 10 x 75mm glass test tubes
and the culture tubes, syringes, and filters were rinsed twice with 300 yuL hexane (total
volume 1.8 ml), by the process just described to remove any adsorbed retinoids. The
hexane was evaporated to dryness under a stream ofN2 and the residue redissolved in 100
pL acetonitrile for HPLC analysis.
3. HPLC Analysis of retinoid standards and standard and samples
Purified retinoids of interest (13-cw-RA, 9-cw-RA, all-fron^-RA, 4-oxo-RA, and
A-hydroxy-RA, all-/ra«5-retinol, all-rrara-retinal, and all-rrawi'-retinol palmitate) were
used as reference standards and internal standards during HPLC sample runs. The
substrate levels in the samples and controls were below the limit ofUV detection,
therefore, the internal retinoid standards were used to determine retention times and
chromatographic quality via UV. UV absorbance spectra (200 - 410 nm) were generated
for ethanol solutions of the retinoids to determine concentrations and absorbance
characteristics. The retinoid concentrations were determined by Beer's law, using the
appropriate absorbance coefficient for each retinoid: all-trans- RA, 45360.4 M 'cm ’; 9-
cis-RA, 36500 M‘‘cm ‘; 13-cis-RA, 38361.08 M ’cm *; 4-hydroxy-RA, 45500 M'‘cm‘‘;
and 4-oxo-RA 54095.72 M ‘cm '. Aliquots containing 500 ng of retinoids were
transferred under gold filtered light into 10mm x 15nim test tubes. The ethanol was
evaporated under a stream ofnitrogen and the retinoids were resolubilized in 200 pi
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HPLC grade ethanol (2.5 /Ug/gl). These retinoid standards were pooled or separately
aliquotted for HPLC analysis.
Several methods are available for normal and reversed phase chromatography of
retinoids (Cullum and Zile, 1986; Wyss, 1990). The preferred solvent system was 25%
acetic acid (2%) in water and 75% acetonitrile at 1.2 ml/min (R. Heyman, personal
communication) to separate zXX-trans RA and its isomers, 9-cis and 13-cis RA. A Partisil
5 ODS-2 250nim x 4.6mm reversed phase Cl8 column (Whatman) was used with a
Waters 625 Gradient HPLC unit or a Perkin-Elmer Series 4 liquid chromatograph
equipped with a variable wavelength UV detector set at 340 nm (LDC Analytical
SpectorMonitor 3100) and a computer integrator (LCI-lOO Laboratory computing
Integrator, Perkin-Elmer). 100 pi samples were chromatographed. Fractions were
collected into 4 ml plastic scintillation vials (Fisher Scientific) using an LKB fraction
collector set at 1 minute intervals.
4. Liquid scintillation counting ofHPLC fractions
The fractions were evaporated by air under a fume hood to reduce the sample
volume by approximately 90% prior to liquid scintillation counting. Liquid scintillation
cocktail (BioSafe II), 3.5 ml, was added to each 4 ml vial and vortexed. The samples
were counted for 5 min per vial in a Beckman LS5000 TA using a digital integration
program for tritium.
5. HPLC and radioactive profiles
Metabolic products from the radioactive incubations were fractionated by HPLC.
As quality control, and to confirm retention times, amixture of the retinoid standards (4-
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0X0 RA, 4-hydroxy RA, 13-cis RA, 9-cis RA, and all-trans RA) was injected prior to and
after the daily sample runs (Fig. 4. A-B, peaks a - d). Since the amount of radioactive RA
in the samples was below the detection limits of the UV detector, the chromatography
was monitored by spiking the reconstituted samples with the same mixture of retinoid
standards prior to injection. The radioactive profiles of the fractions (Fig. 5. A & B,
peaks a - d) were compared to the retention times of the HPLC/UV chromatograms (Fig.
4. A & B, peaks a - d). The first radioactive peak, collected between 0-4 minutes, often
yielded high variability in the counts recovered within an experimental set, but because
this peak coeluted with the solvent front, it was omitted from evaluation.
The radioactive data indicate major peaks in the samples and controls that
correspond to the retention times of the available retinoid standards (Figs. 4 & 5). The
major peaks, as indicated in the figures, were derived directly from cellular or chemical
conversion ofRA. One major radioactive peak collected from cell culture extracts at
about 11 minutes did not correspond to any of the available RA standards. This peak was
designated Unknovra A.
6. Data analysis and statistics
Using the integration printouts, the significant radioactive peaks were manually
selected and the sum of the radioactivity under each peak was calculated. The
radiolabel was located at the 11 and12 carbons within the stable polyene side chain of the
substrate all-Zrotni'-RA, thereby facilitating tracing the radioactive products that resulted
from the original substrate. Since total radioactivity recovery varied within each
experimental group, it was necessary to normalize the data. Equations 1 and 2 illustrate
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the calculations used to determine the amount ofRA added to the samples and the rate of
RA conversion within the samples, respectively. Equation 1 shows the calculation of the
total amount ofRA, both labeled and unlabeled, added to the samples. For Equation 1,
the radioactivity added (11,12-pH]-RA) was 300,000 dpm per sample, thereby limiting
the amount of radiolabeled RA utilized and requiring supplementation with unlabeled
(cold) RA to generate the desired incubation concentration. Equation 2 illustrates
normalization or conversion from peak DPM to rate ofproduct formation or substrate
concentration reduction. An incubation constant was determined for this conversion
(Equation 2). Both controls and experimental samples were converted to pmole/hour
with this constant.
RAadded= [300,000DPMy X ^ ^300.4pg^l000ngj ^^gu^iabeied
49.2pC/ 2.2x1O^DPM mol pg
Equation 1: Calculation of Total ng RA added:
ng RA added= total amount added per sample
300.4 ng/nmol = molecular weight ofRA
49.2 pCi/pmol = Specific activity of 11,12-[ ^H]-RA







Equation 2: Calculation ofmetabolite formation
300.4 ng/nmol = molecular weight of ^H-RA
1 hour = incubation time
ng RA = amount added per sample (Calculated from Equation 1)
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Figure 4. UV profile ofRA standards separated by reversed-phase HPLC using a
Whatman partisil ODS-2 (250mniX4.6nim) Cl8 column eluted with 25%acetic acid (2%)
in water and 75% acetonitrile at 1.2 ml/min. A. Extraction sample with RA standards
containing excess 3,4-didehydro-RA (ddRA); a - 4-oxo RA (6.25min), b - 13-cis RA and
3,4-didehydro RA (15.84) min, c - 9-cis RA (19.33 min), d - all-trans RA (22.23 min). B.
RA standards with excess 5,6 monoepoxy RA; a - 4-oxo RA (6.45 min), b - 13-cis RA








Figure 5. Radioactivity elution profiles of extracts from a representative limb
mesenchyme culture and cell free control treated with pH]-ll,12-all-trans RA. A.
Extracts from Cell free controls. B. Extracts from stage 21-22 distal wing mesenchyme
microculture. Each arrow indicates the relative retention time ofRA isomer standards
from HPLC-UV chromatograms: (A) 4-oxo and 4-hydroxy RA; (B) 13-cis RA and 3,4-dd
RA; (C) 9-cis RA; (D) all-trans RA.
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The control average pmole/hour (rate) was determined for the fractions corresponding to
the experimental peaks. The adjusted rate ofpeak formation was calculated, on the
spreadsheet, by subtracting the cell-free average from each corresponding experimental
peak value. The experimental peak averages, standard deviations (SD), peak means, and
standard errors of the mean (SEM) were calculated using LOTUS 123.
Statistical analyses were performed using GBSTAT3, INSTAT (GraphPad
Software, Inc.) and SIGMASTAT (Jandel Scientific, Inc.) software. Unpaired t-tests
were used to compare region-differences for each metabolite within each stage at each
dosage studied. ANOVA was used to compare stage-dependent differences within both
RA concentration studied. For example, metabolism rates of all-trawr-RA by distal and
proximal mesenchyme from stage 21-22 incubated at physiologic concentrations were
compared. Unpaired t-tests were also used to compare RA concentration-dependent
differences between the same regions at the same stage. For example, the production of
unknown A in stage 25-26 distal mesenchyme was compared at physiologic and
pharmacologic doses. Confidence intervals were set at 95%.
D. Western Blot Analysis
1. Protein Isolation and Gel Electorphoresis
Total cytoplasmic protein was isolated from proximal and distal limb
mesenchyme tissue from stages 21,23, and 26 chick embryos (Hamilton-Hamburger,
1955). For CRABP analysis, cytoplasmic protein was isolated using a modification of
the methods of Siegenthaler (1992) and Ali et al. (1992). Distal and proximal tissue
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were homogenized in a high salt buffer (20mM Tris/HCl, pH 7.8,1 mM EDTA, 0.1 M
NaCl, 1 mM phenylmethylsulfonyl fluride, and 1 //g/ml each of aprotonin, leupeptin, and
pepstatin) using a Bounce homogenizer and centrifuged at 190,000 x g for 30 minutes at
4°C to remove the nuclei and membranes. Protein concentrations were monitored by the
bicinchoninic acid assay (Sigma) and the samples were frozen at -80° C until sufficient
protein (15 jug/well) was available for electrophoresis. Electrophoresis was carried out
using preformed gradient (8%-14%) nondenatixring polyacrylamide (PAGE) gel (Jule) in
a BioRad vertical minigel apparatus. Each well received 15 yug ofprotein Avith 1:1 (v/v)
sample buffer (0.025 M Tris-Hcl, pH 8.3,0.192 M Glycine, 10% glycerol, 0.01
bromophenol blue). The running buffer was modified to eliminate SDS and other
denaturing components (25 mM Tris; 192 mM glycine, pH 8.3). Electrophoresis was
carried out for 4 hours at 30-40 amps.
2. Membrane Transfer
Electrophoresed proteins were transferred to nitrocellulose membranes
(Schleicher & Schuell) with a BioRad wet electrotransfer apparatus using fresh running
buffer (25 mM Tris; 192 mM glycine, pH 8.3). The transfer was for 1 hour at 95 amps in
a cold room. Ice packs and stirring were used to maintain even temperature. After the
transfer was complete, the membrane was blocked overnight at 4°C in phosphate
buffered saline (PBS; 10 mM sodium phosphate; 10 mM potassium phosphate, pH 7.4;
0.9% sodium chloride) with 5% nonfat dry milk, 0.02% merthiolate was added to inhibit
bacterial growth. This overnight blocking was followed by three gentle 15 min washes in
PBS at room temperature.
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3. Western Blotting
After washing, the membrane was incubated overnight at 4°C with polyclonal
antibody (rabbit anti-bovine testis CRABP; Hatori, 1991) solution (1:1000 or 1:2500
dilution in PBS/T (PBS plus 0.05% Tween 20)). This was followed by vigorous washing
in PBS/T with 4-6 changes during 1 hour. Next, the membrane was incubated for three
hours in the cold with secondary polyclonal antibody (goat anti-rabbit/horseradish
peroxidase; Zymed) at 1:10 dilution in TS/T (tris-buffered saline (20 mM Tris-Hcl, pH
7.4,0.3 M NaCl) with 0.05% Tween 20) along with blocking agents (5% non-fat dry milk
and 0.02% merthiolate). A second wash was performed with TS/T for one hour with
vigorous shaking and 6 buffer changes.
4. Western Blot Detection
Western blot detection was performed using the Amersham ECL (enhanced
chemiluminescence) detection system as recommended by the manufacturer. This
involves using a secondary antibody labeled vdth horseradish peroxidase and a
peroxidase substrate that emits light in the presence of the enzyme. Treated blots were
rinsed briefly in TBS (Tris buffered saline; 20mM Tris-HCl, pH 7.4; 0.15 NaCl) prior to
exposure to ECL detection solution. Next, the blots were soaked in ECL solution,
wrapped in cellophane (Saran Wrap) and exposed to Kodak XAR film in a cassette with
an intensifying screen for 5-40 minutes depending on the signal strength. Films were
developed in an X-OMAT processor.
IV. Results
A. Retinoic acid metabolism in the developing limb
The initial objective was to determine whether any stage- or region-dependent
differences in RA metabolism exist in the limb bud that correlate with the proximodistal
differences in RA’s effects on cell proliferation and differentiation (Paulsen et al. 1994;
1998). Mesenchyme cells isolated from the proximal and distal regions ofwing-buds
from stages 21-22,23-24, and 25-26 chick embryo were incubated briefly (1 hour) with
^H-all-rrans-RA at either pharmacologic (136.36 ng/ml) or physiologic (7.5 ng/ml) RA
concentrations. This brief incubation period was designed to avoid metabolic activity
induced by the exogenous RA (ie., RA-induced en2yme synthesis). Extracts of the cells
and medium were analyzed by reversed phase (C-18 column) HPLC. Radioactive peaks
were compared to retention times of authentic retinoid standards to determine the
metabolites generated (see HPLC and radioactive chromatograms. Figs. 4 and 5). Net
cellularmetabolism rates were determined from radioactive scintillation data by
subtracting levels of the peaks generated in the cell-free controls (Fig. 5A) from the
experimental values obtained. (Fig. 5B).
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1. Evidence of region-dependent differences in RA metabolism
Substrate Metabolism: Region-dependent differences in RA metabolism and
metabolite production were evident along the limb bud’s proximodistal axis, (Fig. 6;
Table 1). The distal limb mesenchyme cells metabolized all-tranj'-RA (the substrate) at a
significantly greater rate than the proximal cells (p<0.05) for all of the stages and doses
examined (Fig. 6 A-E; Table 1), except stage 25-26 at pharmacologic doses (Fig. 6F).
Table 1. Net rate (pmole/hour) ofmetabolism of exogenous all-trans-
RA from reaction mixtures incubated at physiologic concentration.
Distal Proximal p-value
ST.21-22 0.34 ± 0.05 0.14 ±0.05 0.008
ST.23-24 0.35 ± 0.05 0.13 ±0.03 0.001
ST.25-26 0.33 ± 0.05 0.02 ± 0.04 0.047
Generation ofPolar Metabolites. The distal cells also produced polar RA
metabolites (4-oxo-RA, 6.25 min. elution time; 5,6-epoxy-RA, 9.02 min.; and unknown
A, 11 min.) at metabolic rates greater than the proximal cells.
4-oxo-RA. Stage 25-26 distal cells incubated at physiological levels produced 4-
0X0 RA at a significantly greater rate than proximal cells (Table 2, Fig. 6C). There are no
significant proximodistal differences in 4-oxo production from cultures isolated from
other stages (Table 2). This may indicate an age-dependent change in RA metabolism in
the proximal cells.
5,6-epoxy-RA. Among the metabolites produced in significant amounts at both
physiologic and pharmacologic RA concentrations studied was 5,6 monoepoxy RA (8.32
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minutes). The retention time of the radioactive peak generated by the limb mesenchyme
cells corresponded to the 5,6-epoxy RA standard retention time. Distal cells produced
significant amounts of this RA metabolite when incubated with physiologic RA
concentrations (stages 21-22 and 23-24) and in the stage 21-22 incubated with
pharmacologic levels (Table 2 and Fig. 6). There is a stage-dependent decrease in 5,6-
epoxy-RA production by distal cells incubated at pharmacologic doses (Fig. 6 D-F). By
stage 25-26, the proximal cells exhibit greater production of this metabolite than that of
the distal cells. Again this may reflect an age-dependent shift in RA metabolic
mechanisms.
Table 2. P-values of region-dependent differences in RA metabolism. Student’s t-test by
limb region. (Distal vs. Proximal, unpaired)
Physiologic Dose (7.5 ng/ml) Pharmacologic Dose (136.36 ng/ml)




































13-cis RA N.S. N.S. N.S. N.S. N.S. N.S.
9-cis RA 0.05
*
N.S. N.S. N.S. N.S. N.S.







* =p^0.05; ** =p^0.01; = p<0.001;N.S. =NO SIGNIFICANT DIFFERENCE
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Figure 6. All-trans RA metabolism by proximal and distal chick wing-bud
mesenchyme. Charts ofRA metabolism and isomer production as calculated from liquid
scintillation data from HPLC fractions ofextracts from incubations at pharmacologic and
physiologic doses. Zero represents control values. Significant region-dependent
differences are marked by an asterisk (*). A-C are those cells incubated at physiologic
RA concentrations, whereas D-F are those incubated at pharmacologic RA
concentrations. (N=24 cultures)
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Unknown A, An unknown peak (unknown A) was consistently generated at
around 11 minutes (Fig. 5). This peak did not correspond to any of the known standards
available (Fig. 4). Here again, distal mesenchyme consistently produced this metabolite
faster than the proximal cells. However, these differences were significant only at
pharmacologic incubations for stages 21-22. Notably, stage 25-26 distal mesenchyme
appeared to utilize unknown A during incubations at the pharmacologic dose. Unknown
A production for both RA dosages studied was consistently lower in the proximal cell
cultures
Generation of Isomers: Significant region-dependent differences in the
production of 13-cw-RA and 9-cm-RA were not detected (Table 2).
2. Evidence ofStage-Dependent Differences in RA Metabolism
Substrate Metabolism: Proximal limb mesenchyme cells incubated with
pharmacologic RA concentrations exhibited substantial stage-dependent differences in
substrate (all-rra«5-RA) utilization (Table 3 and Fig. 6 D-F). By stage 25-26, proximal
cultures incubated with the pharmacologic dose increased their rate of substrate
utilization sufficiently to equal that in the distal cultures. At physiologic RA
concentrations the utilization ofRA by the proximal cells actually decreased with
advancing developmental age (Fig. 6 A-C).
Unknown A. An unknown peak (unknown A) was consistently generated at
aroimd 11 minutes (Fig. 5). This peak did not correspond to any of the known standards
available (Fig. 4). Here again, distal mesenchyme consistently produced this metabolite
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faster than the proximal cells. However, these differences were significant only at
pharmacologic incubations for stages 21-22. Notably, stage 25-26 distal mesenchyme
appeared to utilize unknown A during incubations at the pharmacologic dose as indicated
by the fact that the levels of this metabolite were lower in the experimental cultures than
in the cell-free controls (the bar falls below zero of the graph). Unknown A production
for both RA dosages studied was consistently lower in the proximal cell cultures.
Table 3. Significant stage-related diflerences in RA utilization. One-way ANOVA
(analysis of variance) with Bonferroni corrections.
Retinoid Comparisons alpha
All-trans RA 21-22 prox vs. 25-26 prox (Pharm) p < 0.001
23-24 prox vs. 25-26 prox (Pharm) p < 0.001
23-24 prox vs. 21-22 prox (Pharm) p < 0.001
13-cis RA 21-22 dist vs. 25-26 dist (Pharm) p < 0.05
Unknown A 21-22 dist vs. 25-26 dist (Pharm) p < 0.001
23-24 dist vs. 25-26 dist (Pharm) p < 0.001
Generation of Polar Metabolites:
There were no significant stage-related differences in 4-oxo RA, 5,6-epoxy-RA,
and 9-cis-RA production. The most significant stage-related differences were foimd
among polar retinoids produced by cells incubated at pharmacologic RA concentrations
(Table 3).
Unknown A. Incubation at pharmacologic RA levels resulted in a stage-
dependent increase in unknown A production by the proximal cells, along with a rate
decrease in stage 25-26 distal cells (Fig. 6 D-F). At stage 25-26 (Fig. 6F) the metabolic
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rate for unknown A is below baseline for the distal cultures containing pharmacologic RA
concentrations, suggesting utilization rather than production.
13-cis-RA. At pharmacologic dW-trans RA doses, 13-cw RA utilization
underwent a stage-dependent change distally (Fig. 6 D-F). The distal cells go from
utilization to nearly undetectable levels (at baseline) by stage 25-26. This rate change
may reflect a change in a metabolic pathway that removes13-cis-RA from the cytosol in
the presence ofpharmacologic RA levels.
3. Evidence ofDose-Dependent Differences in RA Metabolism
There are some differences that arose strictly as a result ofRA concentration
levels (Fig. 6). Not surprisingly, the overall rates of substrate removal and metabolite
production were increased in incubations containing the higher pharmacologic RA levels
(364 nM) (Fig. 6 D-F). The reaction rates were roughly 10-fold that at physiologic levels
(7.5 nM) (Fig. 6 A-C). This indicates that the reactions are driven to a higher rate by the
overwhelming excess ofRA found at pharmacologic concentrations. Certain age-
dependent modulations in metabolism were more obvious at pharmacologic levels than
at physiologic levels. In particular, there was an age-dependent increase in RA utilization
by proximal cells incubated with pharmacologic RA concentration (Fig. 6 D-F).
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Table 4. Dose-dependent differences in cellular rates of retinoid metabolism and
















4-0X0 ** ** * **
5,6-epoxy *** *** ** ***
Unk A *** ** N.S. *** ***
13-ci s * N.S. N.S. ** N.S. *
9-cis N.S. N.S. *** N.S. ** N.S.
all-trans *** *** *
* =p<0.05; ** =p^0.01; =p^0.001.
Substrate metabolism. There were significant dose-related differences in RA
utilization among all the cells studied. Table 4 shows that concentration-dependent
differences exist between stages and regions. For all-trans RA metabolism, the most
significant differences (indicated by triple asterisks) were among distal and proximal cells
from stages 21-22 and 25-26 and the distal cells from stage 23-24. The most notable
dose-related difference in RA metabolism was found between stage 25-26 proximal
mesenchyme (Fig. 6 C&F). These cells utilized available RA at a significantly greater
rate in cultmes incubated at pharmacologic concentrations, similar to the corresponding
distal cells, than did the stage 25-26 proximal cells incubated at physiologic
concentrations. This may signal a stage dependent enhancement of a metabolic
mechanism that requires higher substrate concentrations to act on RA.
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Generation of Polar Metabolites. Accompanying the dose-dependent increase in
RA metabolism/degradation is a nearly 10-fold increase in polar metabolite (4-oxo- RA,
5,6-epoxy-RA, Unknown A, 13-cis RA, and 9-cis RA) production in the mesenchyme
cells incubated at pharmacologic RA concentrations as indicated by the ordinate axes of
the charts in Figure 6. Statistical comparison of the dose-related modulations are shown
in Table 4. Significant differences are marked for comparisons with p-values less than or
equal to 0.05 or greater than a 95% confidence interval. There were a few significant
differences among cells that produced 9-cis and 13-cis RA. There was no significant
dose-related difference in net 13-cis RA generation among cells from stage 21-22
proximal, 23-24 distal, and 25-26 distal. Significant differences in net 9-cis production
appeared in only stage 23-24 distal and 25-26 distal limb mesenchyme (Table 4 and Fig.
6 B&E, C&F).
In summary, the majormetabolic differences indicated by these studies are as
follows. There are region-dependent, dose-dependent and stage-dependent differences in
RA metabolism in the developing limb bud. At the physiologic concentration ofall-trans-
RA, distal limb mesenchyme from each stage metabolized RA faster than the proximal
mesenchymal cells. At pharmacologic doses ofRA, there is an age-dependent moderation
of the differences between the distal and proximal rates ofRA metabolism. The results
also indicate that there are proximodistal differences in the rate ofRA metabolism in the
developing chick limb bud at both physiologic and pharmacologic concentrations ofRA.
Incubations with the physiologic concentration revealed a consistently greater production
ofunknown A by distal cells than by proximal cells.
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B. CRABP Isoforms Expression Patterns
This study was undertaken to test the hypothesis that RA metabolism is correlated
with any spatiotemporal differences in CRABP expression in the limb during outgrowth.
Specifically, the proximodistal pattern ofCRABP isoform was determined to have a
stage-dependent distribution. Polyclonal rabbit-anti-bovine testis CRABP antibody
supplied by Dr. Joseph Napoli (State University ofNew York, Buffalo) was used for
Western blotting studies. Cytosol was isolated from whole limb, distal and proximal limb
mesenchyme tissue (Siegenthaler, 1990; Siegenthaler and Saurat, 1987). Western blots of
SDS denaturing gels (Fig. 7) revealed only a single, antibody-positive, CRABP band.
At least two CRABP isoforms are known to exist in mammals, CRABP-I and
CRABP-II (Bailey and Siu, 1988; Kitamoto et al. 1988; Astrom et al. 1991). In the
present study; Western blot analysis ofnon-denatiuing gels of cytoplasmic proteins from
distal and proximal mesenchyme shows that two isoforms are expressed in both regions
(Fig. 8) of the developing chick limb as well.
There are clear stage-dependent, and region-dependent, differences in CRABP
isoform expression. CRABP I expression declines distally with increasing embryonic age
(Fig. 8) Proximally, CRABP II expression decreases in an age-dependent maimer (Fig.
8). Overall, there is an age-dependent decline in CRABP isoform expression. CRABP I
expression is more prevalent and persistent proximally, whereas CRABP II is more
intensely expressed in the limb’s distal mesenchyme, but declines with age.
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F^re 7. Western blot detection of CRABP from SDS-PAGE of total protein isolated
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Figure 8. Non-denaturing gel electrophoresis ofdistal (top box) and proximal (bottom
box) proteins from stages 21-22,23-24, and 25-26 wing-bud (from left to right). Western-
blot probing with polycbnal anti-CRABP antibody yield CRABP I (lower band) and
CRABP II (upper band). Non-denaturing gel electrophoresis does not permit the use of
molecular weight determination, but is based on the native conformation of the proteins.
V. Discussion
A. Patterns ofRetinoic Acid Metabolism in the Developing Chick Limb
This study represents the first analysis of the pattern ofRA metabolism in the
developing limb (Fig. 6) Table 5 summarizes the data on RA utilization and CRABP
isoform expression in the distal and proximal regions ofembryos from stages 21 through
26. Others have examined the generation ofRA from ROH (Thaller and Eichele, 1988),
but in the time since that study there have been no published reports of the pattern of
disappearance RA, a potent modulator ofgene expression, in the limb. This study
represents a critical step in the understanding ofRA's role in limb development. Only by
understanding both RA synthesis and degradation can one begin to gauge the steady-state
RA levels normally encountered by limb mesenchymal cells. The discovery of
proximodistal differences in RA metabolism during limb development clearly advances
the understanding of the mechanisms underlying RA's role in limb outgrowth.
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Table 5. Summary of region-related correlations between dose-related RA







21-22 Distal -0.34±0.05 12.76 35.13
Prox -0.14±0.04 14.89 22.08
23-24 Distal -0.35±0.05 3.71 23.26
Prox -0.13±0.03 11.09 11.71
25-26 Distal -0.33±0.04 none detected 6.77
Prox -0.02±0.50 10.14 6.15
These results definitively show that during the period of limb outgrowth, the
capacity for RA removal or utilization is greater in the limb's distal mesenchyme than in
its proximal region. This is consistent with a substantially lower steady-state RA
concentration in the distal than in the proximal limb mesenchyme. Unfortimately, the
levels ofendogenous RA in these tissues are too low to be directly measured by any
methods currently available. Not only are the tissues of interest exceedingly small, but
new and highly sophisticated methods would have to be developed to separate even lower
concentrations of fi^ee vs bound RA metabolites from these embryonic samples.
The significance of this faster RA metabolism and evidence of lower steady-state
concentrations of available RA in the distal mesenchyme is validated by the central
importance of this tissue in normal limb development. The distal mesenchyme is critical
to continued limb-bud outgrowth. Without this outgrowth, limb development cannot
occur. The most significant developmental characteristics of these cells are their capacity
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to maintain a rapid rate ofproliferation and their resistance to differentiation. Together
with RA's known capacity to induce differentiation by a wide variety ofundifferentiated
cells (Spom et al. 1994; Berry, 1997) the findings of this study are consistent with a role
for RA degradation in maintaining the stem-cell character of the distal cell population
(Paulsen, 1994). The question thus arises whether RA degradation is necessary for
continued limb outgrowth. Several lines of evidence indicate this may be the case. The
ability of pharmacologic doses of retinoids, especially RA, to halt limb outgrowth in vivo
is well known (Hofinann and Eichele, 1994; Maden and Pizzey, 1997; Maden, 1998).
Based on the present findings, it seems likely that such high doses may overwhelm
the metabolic capacity of the distal mesenchyme, resulting in RA concentrations sufficient
to induce cytodifferentiation despite the protective mechanism in place in this region. This
view is fiirther supported by evidence that mesenchymal cells, isolated from different
positions along the limb's proximodistal axis and placed in serum-ffee culture, respond
differently to exposure to RA at identical concentrations (Paulsen et al. 1994,1998).
Physiologic RA concentrations have little effect on the proliferation ofproximal limb
mesenchyme, but actually enhance proliferation by the distal cells. Pharmacologic RA
concentrations dramatically inhibit in vitro proliferation by proximal cells but not in the
distal cell cultures. This indicates that proliferation is in some way protected in the distal
cells. The faster rate ofRA metabolism by the distal cells in the present study provides
some evidence of this protective mechanism.
Further, the fact that physiologic concentrations ofRA can enhance distal cell
proliferation in vitro (Paulsen et al. 1994, 1998), suggests that the mechanism may not be
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exclusively protective and geared toward RA degradation, but may also assist in
maintaining an optimal steady-state RA concentration in this tissue to promote outgrowth.
There is also evidence that the AER's well-accepted role in promoting limb
outgrowth operates, at least in part, through this mechanism. Several studies have
indicated that the ability ofRA-soaked beads implanted in the limb bud's anterior margin
to inducemirror-image limb duplication involves an induction of ectopic proliferation and
novel gene expression (Tickle, 1991; Tamura and Ide, 1993), and that this response to RA
is restricted to cells between the bead and the AER. It thus appears that a signal from the
anterior part of the AER is involved in regulating the responses of the underlying
mesenchyme to low levels ofRA.
Recent studies have indicated significant anteroposterior differences in certain
signals emanating from the AER. Specifically, the entire AER expresses FGF-8, a
member of the fibroblast growth factor family (Crossely et al. 1996), while only the
posterior portion of the AER expresses another member of this family, FGF-4, as well
(Niswander and Martin, 1994). The inability ofRA-soaked beads implanted into the
limb's posterior margin to induce the same level ofproliferation in the distal mesenchyme
as occxirs in response to anterior bead implants (Tickle and Eichele,1985), may reflect that
the added FGF-4 signal locally alters the RA metabolic activity.
It is thus conceivable that FGF-8 and FGF-4 emanating from the AER have
distinct effects on RA metabolism by the underlying distal mesenchyme. The effect of
these signals on the rate and nature ofRA metabolism in these cells remains to be directly
tested. Such tests are now possible using the methods developed for the present study and
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will provide additional insight into this proposed mechanism for promoting limb-bud
outgrowth. Effects of these signals on other aspects of the RA signal-transduction
mechanism are also possible. However, analyses ofeffects on RA metabolism, and thus
on signal availability, would seem to be a more appropriate next step in unraveling this
mechanism.
B. Products ofRA Metabolism
Having established the existence of regional differences in the rate ofRA
metabolism in the developing limb, it is appropriate to begin considering the downstream
mechanisms whereby such differences might influence developmental cell behaviors. As
discussed above, simply reducing the availability ofRA in the distal region could protect
cells in the region from premature differentiation and so preserve this stem cell population
so critical to continued limb outgrowth. Such substrate removal could also maintain levels
that are optimal for cell function. However, there is no guarantee that the metabolism
observed solely reflects signal removal. The possibility that the metabolism generates new
signals, perhaps more potent but with different effects, deserves some consideration.
Generation ofdifferent metabolites by different limb regions could suggest that the type
ofmetabolism occurring is as important as the metabolic rate in regulating these
developmental events. The nature of the metabolites generated thus needs to be examined
and compared with what is known about retinoid signaling in better characterized systems
(Vieira, 1998).
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Reports in the literature indicate that the metabolites generated in the present study
are consistent with RA inactivation. The predominant metabolite produced by distal limb
mesenchymal cells, from the al\-trans-RA substrate, was 5,6-epoxy-RA. This metabolite
is known to be far less bioactive than all-Zran^-RA in human and mouse skin (Reynolds et
al. 1993) and appears to be an isomer targeted for elimination by subsequent
glucuronidation in rats (Napoli et al. 1982; Napoli, 1996). These findings are thus highly
consistent with the suggestion that a major outcome ofRA metabolism in these tissues is
inactivation of the RA signal. Although 5,6-epoxy-RA bioactivity has proven to be very
limited in other systems, there is no information about its activity in the embryonic chick
limb. Because it is a major RA metabolite in the developing limb, characterization of its
effects on the proliferation and differentiation of limb mesenchyme is now clearly
warranted.
Another metabolite consistently produced in these cultures was designated
Unknown A because its elution time did not correspond with any available retinoid
standards. Although it was produced at levels that were consistently lower than for the
5,6-epoxy metabolite. Unknown A showed only significant stage- and region-dependent
differences in production at pharmacologic doses. One notable correlation between the
patterns of substrate utilization and Unknown A production was seen in the cultures of
older (stage 25-26) cells in the presence ofpharmacologic all-tra/ii'-RA concentrations
(Fig. 6F). Here there was a dramatic shift from Unknown A net production to net
utilization by the distal mesenchyme. This shift, however, is only one of a number of
changes seen only in cultures of cells from these older limbs and it occurred only in the
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presence ofpharmacologic substrate concentrations. As discussed below, this shift may
reflect the appearance of an alternate, concentration-dependent metabolic pathway
accompanying advancing developmental age. Again, additional studies of the effects of
this metabolite are now warranted but must await the development of a method to prepare
this metabolite in quantities large enough to allow chemical characterization to determine
its structure and use in bioassays of cellular effects.
Small but measurable amounts of4-oxo-RA, another polar metabolite, were
generated in nearly all of the cultures. This is another metabolite that has long been
considered a degradative product ofRA metabolism. Only recently have any studies been
published demonstrating developmental effects of this metabolite, and only at relatively
high concentrations (Chambon, 1996; Morriss-Kay and Sokolova, 1996; reviewed by
Means and Gudas, 1995). This and the fact that there were essentially no region-
dependent differences in the generation of this metabolite in this study (Fig. 6 A-F) argue
against a significant role for this compound in any region-dependent differences in effects
ofall-/ra«s-RA on these cells. It should be noted that in cultures of the older (stage 25-
26) limb bud mesenchymal cells incubated at physiologic RA concentration, there was
evidence of faster 4-oxo-RA production by the distal than the proximal cells. The
possibility that this is one of several indicators of an age dependent shift in the
mechanism ofRA metabolism will be discussed below.
Another small, but potentially significant, region-dependent difference in RA
metabolism in these studies was observed only in the cultures of the yoimgest (stage 21-
22) cells receiving physiologic levels of all-/ranj-RA substrate. Here, the distal cells
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produced significantly more 9-cis-RA than did the proximal cells (Fig. 6A). This
difference is worth noting because this isomer has been reported to have 25 times the
bioactivity ofaX\-trans RA and because it has been shown to bind selectively to different
nuclear receptors (i.e., RXRs vs RARs) than does the dM-tram isomer (Heyman et al.
1992; Levin et al. 1992). On the other hand, there were no significant, region-dependent
differences in the generation ofthis metabolite in any of the other cultures (Fig. 6 B-F),
Further, this metabolite was generated at minute concentrations that were near the limits
ofquantitation of the methods used in this study.
C. RA Binding Proteins
While evidence of developmentally regulated patterns in the expression of
CRABPs continues to mount, there is no agreement on their precise role in development.
It has been noted in several studies that CRABP expression occurs preferentially in a
number of embryonic tissues known to be especially sensitive to the teratogenic effects of
exposure to pharmacologic doses of retinoids (Balling, 1990; Dencker et al. 1990; Dolle,
1990; Vaessen, et al.., 1990; Gustafson et al. 1993; Naploi, 1996; Dong et al. 1999). This
has led some investigators to suggest a role for CRABP in sequestering RA or promoting
its metabolism (Vaessen et al. 1990; Ong et al. 1994; Maden, 1994). This perspective is
supported by evidence that CRABP overexpression promotes RA metabolism in other
embryonic cells (Boylan and Gudas, 1992) and by evidence that other members of this
protein family are known to bind ROH and to contribute to directing its metabolism
(Eriksson et al. 1984; Napoli, 1996; Newcomer et al. 1998). Thus promoting metabolism
66
is the most likely CRABP function and provides the rationale for analyzing the
relationship between CRABP expression and RA metabolism in the present study.
Analyses ofa role for CRABP in metabolism are complicated by the existence, in
most vertebrates, of two CRABP isoforms, CRABP I and CRABP II (Ong et al. 1994;
Dong et al. 1999). No reagents are currently available to distinguish, in situ, between the
two CRABP isoforms in chick embryos. There are no CRABP-isoform-specific
antibodies or riboprobes for use in chick embryos. However, a polyclonal antibody
obtained from Dr. Joseph Napoli (SUNY, Buffalo) binds with equal affinity to both
isoforms in Western blots. Owing to the slightly different migratory characteristics of
these protein isoforms in non-denaturing gels (Maden, 1994), it is therefore possible to
obtain semi-quantitative estimates of relative levels ofexpression in extracts of
mesenchyme surgically removed from different limb regions. This approach allowed
demonstration ofsignificant region-dependent differences in the amounts and types of
CRABP expression in the chick limb bud.
The present study indicated that the CRABP II isoform expression (Fig. 8) is best
correlated with the more rapid metabolism ofRA by the distal mesenchyme (Fig. 6). It is
expressed at higher concentrations than proximally, is present throughout the period of
limb outgrowth studied, and declines with advancing developmental age. Distal CRABP I
expression also declines with advancing age but appears to decline more rapidly, dropping
to undetectable levels by stage 25-26 in this region. CRABP II is present proximally, but
at levels approximately equal to CRABP I at stage 21-22, and declines with age. Proximal
CRABP I levels decline gradually with age. Thus the regions are demonstrably different
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with respect to CRABP isoform expression. The expression pattern is consistent with
both isoforms having a role in promoting RA metabolism, but with the presence of
CRABP II being correlated with a more efficient effect on metabolism. It is not yet
possible to assign any causal relationship between the levels ofCRABP expression,
isoforms present and the rates ofRA metabolism demonstrated. Nevertheless, there is
sufficient correlation to suggest pursuing further studies of this association (Dong et al.
1999).
Several investigators have probed chick embryo cDNA and genomic libraries
searching for evidence of a chicken CRABP II gene without success (Susan Smith and
Malcolm Maden, personal communications). Thus while studies with chicken CRABP I
should be possible immediately, it is conceivable that there is only one chicken CRABP
gene and that in chickens, the second isoform is generated entirely by post-transcriptional
modifications of the transcript (e.g., alternative splicing) or post-translational
modifications of the protein itself (e.g., proteolytic cleavage or glycosylation). This
possibility could delay the assignment of isoform specific roles to CRABP in RA
metabolism.
D. Evidence ofAn Alternative Pathway for RA Metabolism in Developing Chick Limbs
Among the more interesting, if rather speculative, aspects of this work is the
indirect evidence for the development of alternative pathways for RA metabolism in the
limb as the period of limb-bud outgrowth draws to a close by stage 28 ofchick embryonic
development. This suggestion is deduced fi'om the stage-dependent trends observed in the
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RA metabolic profiles of the cultured cells (Fig. 6) and the accompanying decline in the
expression ofboth CRABP isoforms observed in Western blots of limb mesenchymal cell
extracts (Fig. 8).
At physiologic substrate concentrations, the RA metabolites (Fig. 6 A-C) are
relatively consistent from stage to stage. The only notable age-dependent changes are the
disappearance, after the yoimgest stage (21-22), of the significant proximodistal
differential in the generation of9-ci5-RA; the disappearance at the oldest stage (25-26), of
the significant proximodistal differential in the generation of 5,6-epoxy-RA; and the
appearance at this later stage of a significant proximodistal differential in 4-oxo-RA
generation. Nevertheless, there is an indication here of some shift in the metabolic
pathway even at this lower substrate concentration.
The age-dependent differences are more pronoimced in cultures exposed to
pharmacologic doses of all-/ra«^-RA (Fig. 6 D-F and Table 2). Here, the proximodistal
differential in substrate utilization, which was greatest in the younger (stage 21-22)
cultures, diminishes at stage 23-24 and disappears by stage 24-25. This age-dependent
shift in substrate utilization rate, is accompanied by changes in the relative production rate
of the metabolites. Unknown A production, which was significantly faster in distal stage
21-22 mesenchyme, becomes insignificantly different from that in the proximal cultures at
stage 23-24 and then reverses to a situation where this metabolite disappears from the
distal cultures faster than in the cell-free controls (signaling utilization) while its
production by the proximal mesenchyme increases. The significant proximodistal
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differential in 5,6-epoxy generation is lost, at this higher substrate concentration, by stage
23-24, earlier than for the same change seen at the lower concentration.
Together these profiles suggest the appearance ofan alternative pathway for RA
metabolism with advancing age. Comparison of the metabolic profiles for stage 25-26
cultures exposed to physiologic versus pharmacologic all-Zran^-RA substrate
concentrations, suggests that the alternative pathway requires higher RA concentrations
than the original and therefore that the affinity of the metabolic pathway for RA as a
substrate may be less. This may indicate that RA is not the primary substrate for the
alternative pathway. It should be emphasized that this alternative pathway is not induced
by the higher RA concentration since the one hour incubation period in this study was not
sufficient for novel proteins to be expressed.
The age-dependent decline ofexpression ofboth CRABP isoforms presents
additional evidence that a change may be occurring in the mechanism ofRA metabolism
within the limb mesenchyme. If indeed CRABP has a prominent role in RA metabolism
during the period of limb outgrowth, its age-dependent decline in abundance would
dictate the need for an alternative mechanism for RA metabolism, possibly resulting in
changes in the metabolites generated.
The potential existence of an alternative RA metabolic pathway, even one that is
less efficient than the original, is underscored by the results of studies in which expression
of one or both CRABP isoforms were knocked out by homologous recombination in
transgenic mice (Lampron et al. 1995). One reason that it has been so difficult for
investigators to agree on a specific developmental fimction for CRABP, despite
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suggestive patterns of expression, has been the xmremarkable developmental impact
(except for a fewminor limb defects) of knocking out CRABP expression in these
transgenics. The existence of an alternative mechanism for RA degradation would suggest
a means for rescuing these embryos from potentially devastating structural anomalies.
Since the defect would have been present in such mice long before the normal patterns of
CRABP expression are established (i.e., from conception), the possibility exists that an
alternative pathway for RA metabolism could be sufficiently upregulated in time to rescue
the transgenics from severe defects that might otherwise result from an inability to
express CRABP. Thus utilizing targeted misexpression ofCRABP isoforms within
specific embryonic tissues during specific times ofdevelopment, rather than knocking out
CRABP expression from conception, might be a more productive approach to unraveling
the role ofCRABP in these developmental processes (Lampron et al. 1995; Burke and
Tabin, 1996; Bellirsch et al. 1996).
E. A New Model for the Regulation of Limb Outgrowth
The present study provides data that suggest extending the current model of the
AER’s role in promoting limb outgrowth to include a role for CRABP and RA
metabolism (Fig. 9). The paradigm proposed here is not intended to be the final answer to
the question of the mechanism behind the AER’s effect, but rather to serve as a basis for
further experimentation.
FGF-8 is known to be synthesized by the AER (Crossley et al. 1996). The well
known matrix-binding properties of the secreted FGFs would serve to limit the diffusion
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ofFGF-8 through the distal mesenchyme to the region directly beneath the AER (i.e. the
progress zone). It is proposed that among this signal’s effects is enhancement of CRABP
II, and perhaps CRABP I, expression in the progress zone. There, CRABP is proposed to
promote a more rapid rate ofRA metabolism, thereby helping to establish a zone in which
lower steady-state levels ofRA prevail. The lower RA levels in the progress zone would
then establish a protected site in which the stem-cell characteristics of the embryonic
distal mesenchymal cells are preserved. This would maintain proliferation and prevent
precocious differentiation. At the same time, overwhelming this mechanism with an
excess of exogenous RA would be expected to cause premature differentiation of the stem
cells and to halt further outgrowth. As growth pressure in the rapidly dividing distal
mesenchyme forces cells to exit the proximal margin of this protected area, the higher
steady-state RA levels encountered would allow differentiation. This would include
expression ofphenotypic characteristics, some which had been latently programmed in
the progress zone and others acquired through interactions with more proximal tissues. In
this way the same stem cell population could give rise to progressively more distal
mesenchyme-derived skeletal structures, and allow for local influences to participate in
shaping the limb skeleton
Several aspects of this model (Fig. 9) will require direct testing. First, the ability
ofFGF-8 to promote RA metabolism, as seen in the present study, will have to be tested
in vitro. Itwill be critical to show that metabolites with substantially less bioactivity are
generated. Thus it will also be necessary to examine the effects of these metabolites (e.g.,
5,6-epoxy-RA and 4-oxo-RA) on the proliferation and differentiation ofwing bud
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mesenchymal cells. Similarly, the effects of FGF-8 treatment on the levels ofCRABP
isoform expression will also require testing to document the anticipated enhancement of
expression by these cells. Finally, direct testing of the role of enhanced CRABP
expression in the promotion ofRA metabolism by these cells will need to be documented.
Only after these criteria are metwill it be reasonable to conclude that the proposed model
for the role ofRA in regulating limb-bud outgrowth is correct.
F. Summary and Conclusions
This is the first demonstration ofage-related proximodistal differences in RA
metabolism and product formation in the developing chicken limb. It was hypothesized
that RA metabolism may be a developmental mechanism for minimizing the teratogenic
effects ofRA on limb outgrowth. In keeping with this theory, it was found that serum-
free cultures ofdistal limb mesenchyme metabolized RA faster than the cultures of
proximal mesenchyme cells, the notable exception being the stage 25-26 limb
mesenchyme incubated at pharmacologic concentration where there was no difference
between distal and proximal rates ofnet RA utilization (Fig. 6 and Table 2).
The possibility that mesenchymal RA metabolism produces new, possibly more
potent, signals was considered since the different metabolites may suggest whether
metabolism is geared toward removal or generating bioactive or bio-inactive metabolites
within the different limb regions. Peaks were identified for 4oxo-RA, 5,6-epoxy-RA, 13-
cis-RA and 9-cis-RA and an unknown peak A. 4-oxo-RA, 13-cis-RA and 9-cis-RA are











Figure 9. TheoreticalModel ofLimb Ou^rowth. FGF-8, fiomthe AER, difiuses into
the nearly mesenclQane cells to enhance CRABP activity or e>q>ression. In turn, CRABP
promotes RAmetabolism in order to avert precocious differentiation and to preserve the
stem-cell characteristics ofthe distal mesmiclqnne.
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5,6-epoxy-RA and unknown A are currently unknown in the limb bud. There were
region- and stage-dependent differences in 5,6-epoxy RA (Table 2) and unknown A
(Tables 2 and 3) that correlated with the added RA concentration during incubation.
Thus, the stem cell population at the distal tip of the limb appears to be protected from
any precocious differention by maintaining low steady-state concentrations ofRA or
converting excess RA to a less bioactive form.
CRABPI and II expression generally declined with advancing age in both
proximal and distal mesenchyme. Although present at lower levels than in the younger
mesenchyme, more CRABP I remained than CRABP II in the proximal mesenchyme
whereas detectable CRABP I disappears completely in the distal mesenchyme by stage
25-26 (Fig. 5). These results from Western blots of non-denaturing gels are the first
demonstration of a proximodistal pattern ofCRABP isoform expression in chick wing
buds. Searches of the current cDNA and genomic libraries show no evidence of a chicken
CRABP II gene, thus indicating that a second CRABP isoform might have been generated
by post-transcriptional modifications. These studies not only add to the mounting
evidence ofdevelopmentally regulated patterns ofCRABP expression but also provide
insight into the function of the isoforms in promoting RA metabolism by correlating their
presence to the metabolism data.
Stage- and region-dependent correlation ofRA metabolism with CRABP
expression patterns suggest that distal CRABP II is linked to promoting efficient RA
metabolism regardless of the age-dependent decline in total distal CRABP levels.
However, due to an age-related increase in proximal RA metabolism, incubations with
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pharmacologic RA concentrations show indications of an alternative metabolic pathway
that may not require the presence ofCRABP, but may be the result ofeither enzyme
maturation with advancing embryonic age or the utilization of an alternative enzyme
system. Nonetheless, these correlations show that the embryonic limb has the short term
capablity to minimize the deleterious effects ofexcess RA, ifnot entirely via CRABP
then through alternative routes when the initial CRABP resources are exhausted or
overwhelmed.
As outgrowth proceeds along the proximodistal axis, the rate ofproliferation of
the distal mesenchyme must be carefully maintained. Differentiation begins once these
mesenchymal cells leave the proliferative milieu of the progress zone. Increased RA
concentrations may promote precocious differentiation due to its availability to interact
with regulatory genes via RARs and RXRs. Genes with promoters that are recognized by
these nuclear binding proteins may be turned on at the wrong time, thereby resulting in
precocious development. Alternatively, genes responsible for growth regulating factors
may be turned off, thereby preparing the cell for specialized development. The findings
of this study are consistent with the possibility that CRABP serves to inhibit precocious
differentiation in the distal mesenchyme by regulating the cytoplasmic RA levels and
thereby influencing RA’s activity at the molecular level through its interaction with RARs
and RXRs. Growth thus appears to be enhanced when the distal RA concentration is kept
to aminimum with the help ofCRABP.
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